Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Deoxycytidine
  • Leiomyosarcoma
  • Paclitaxel
  • Taxoids
  • Uterine Neoplasms

abstract

  • Gemcitabine plus docetaxel is tolerable and highly active in treated and untreated patients with LMS.

publication date

  • June 15, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.11.050

PubMed ID

  • 12065559

Additional Document Info

start page

  • 2824

end page

  • 31

volume

  • 20

number

  • 12